This presentation provides an overview of liver fibrosis, its formation, and the use of biomarkers in different stages. It compares the biopsy and biomarker methods for diagnosing liver fibrosis and highlights the pitfalls of liver biopsy. The presentation also discusses the different types of biomarkers and their development, prognosis, and interpretation. It explores the role of proteomics and genetic markers in diagnosing liver fibrosis. The conclusion emphasizes the importance of these techniques in understanding the pathogenesis of the disease and facilitating its proper diagnosis.